An appropriate organisation of muscles is crucial for their function, yet it is not known how functionally related muscles are coordinated with each other during development. In this study, we show that the development of a subset of functionally related head muscles in the zebrafish is regulated by Ret tyrosine kinase signalling. Three genes in the Ret pathway (gfra3, artemin2 and ret) are required specifically for the development of muscles attaching to the opercular bone (gill cover), but not other adjacent muscles. In animals lacking Ret or Gfra3 function, myogenic gene expression is reduced in forming opercular muscles, but not in non-opercular muscles derived from the same muscle anlagen. These animals have a normal skeleton with small or missing opercular muscles and tightly closed mouths. Myogenic defects correlate with a highly restricted expression of artn2, gfra3 and ret in mesenchymal cells in and around the forming opercular muscles. ret+ cells become restricted to the forming opercular muscles and a loss of Ret signalling results in reductions of only these, but not adjacent, muscles, revealing a specific role of Ret in a subset of head muscles. We propose that Ret signalling regulates myogenesis in head muscles in a modular manner and that this is achieved by restricting Ret function to a subset of muscle precursors.
INTRODUCTION
Movement, eating and vocalisation require the action of functionally related muscles. In order to generate functional musculoskeletal systems different populations of cells need to be coordinated in their development. In the head, functionally interacting muscles arise from different pharyngeal arches and it is not known whether muscles possess specific identities that relate to their subsequent function. The basis for establishing differences between muscles derived from the same pharyngeal arch is not understood, as they arise from common anlagen. The muscles of mastication and facial expression in mammals are derived from mesoderm of the first and second pharyngeal arches, respectively. In fish, mesoderm from the first and second arches form muscles required for jaw opening, jaw closing and respiration (Edgeworth, 1935). Differences in the shape and function of muscles in mammals and fish reflect extensive changes to the head skeleton and associated muscles following their divergence. Skeletal perturbations result in a disruption of the associated muscles, suggesting that morphogenesis of these two tissues is co-dependent, but how this relates to muscle shape and size is not clear. Head muscles do not appear to possess distinct identities during development that are important for their subsequent shape or function. Engrailed 2 (En2; Eng2a – Zebrafish Information Network) is a homeodomain protein expressed specifically in muscle precursors in the dorsal part of the first pharyngeal arch (Hatta et al., 1990), but does not appear to confer specificity to the muscle (Degenhardt and Sassoon, 2001). The basic helix-loop-helix genes capsulin (Caps; Tcf21 – Mouse Genome Informatics) and musculin are expressed in all pharyngeal arch muscles, but double mutant mice lack masticatory muscles derived only from the first arch (Lu et al., 2002). Caps and Musculin are repressors of transcription and are believed to inhibit myogenic regulatory factor (MRF) genes that regulate differentiation (Buckingham, 2006). In mouse, the MRFs Myf5 and Myod (Myod1 – Mouse Genome Informatics) function redundantly to promote pharyngeal arch myogenesis (Kassar-Duchossoy et al., 2004), whereas in zebrafish, only Myod (Myod1 – Zebrafish Information Network) is required (Hinits et al., 2009). Muscle differentiation involves expression of muscle actin and myosin genes; individual head muscles express different myosin type genes, but this does not correspond to the pharyngeal arch from which they originate (Marcucio and Noden, 1999; Hernandez et al., 2005; Elworthy et al., 2008). This diversity in myosin gene expression suggests that head muscles do possess distinct identities, but how these identities are specified is not understood.
The Ret tyrosine kinase signalling pathway is crucial for the development of several neuronal and neural crest lineages, but has not previously been implicated in muscle development (Enomoto, 2005). Ret receptors activate a number of intracellular signalling pathways in response to signalling from glial derived neurotrophic factor (GDNF) family ligands (GFL), mediated through specific receptors (Gfra). In mammals, the Gfra receptors are bound specifically by GDNF, neutrophin, artemin (Artn) and persephin (Airaksinen and Saarma, 2002). Gfra3 is specifically activated by Artn and not by other family ligands (Baloh et al., 1998). Binding of Gfra receptors by the appropriate GFL induces Gfra dimerisation and the activated GFL-Gfra complex then promotes Ret dimerisation and, hence, activation (Airaksinen and Saarma, 2002).
In this work, we identify a novel role for Ret tyrosine kinase signalling during the development of a functionally related set of head muscles in the zebrafish. We show that Ret signalling acts to specifically regulate myogenesis in muscles attaching to the opercular bone. Specific activation of Ret signalling is achieved through the restricted expression of both ret (ret1 – Zebrafish Information Network), gfra3 and an activating ligand, artemin2 (artn2), in cells associated with opercular muscles. The specificity of the muscle phenotype in Ret signalling mutants reveals an unexpected modularity of head muscle development that does not correspond to the origin of the muscles from a particular pharyngeal arch, but instead reflects the subsequent function of the muscles.
MATERIALS AND METHODS
All protocols used were as described previously (Nusslein-Volhard and Dahm, 2002; Westerfield, 2007) except those described below.
Generation and identification of mutants
The stumm (stm) mutant (allele hy024) was identified in a large-scale n-ethyl-n-nitrosourea (ENU) mutagenesis screen (Tübingen 2000 Screen Consortium). stmhy024 was mapped to linkage group 14 by bulk segregation analysis and fine mapped using 1000 embryos to a 0.2 cM interval between z1812 and z28688. Mapping was confirmed with a single-nucleotide polymorphism (SNP; 1204a) to position the locus 0.2cM towards the centrosome from z1812 at 38.1 (MGH mapping panel); the map position of gfra3 was confirmed on the T51 radiation hybrid panel. stmhy024 mutants and wild-type (WT) siblings were identified by sequencing a 532 bp region of exon 4 from gfra3 amplified with primers gfra3-1 (GTACCGGGTTGGCTTAGATTC) and gfra3-2 (GTAGGAACAGGAGGGCACAA). The ret mutant (rethu2846) was identified by TILLING in the Sanger Zebrafish Mutagenesis Project and has a predicted stop codon at amino acid position 229 in the extracellular domain of the protein (www.sanger.ac.uk/resources/zebrafish/). rethu2846 mutants were genotyped by PCR to amplify a 542 bp fragment then tested for the presence of a new Hpy118I using primers Ret3-5 (TCGACGACTCCACTTCTGA) and Ret3-6 (GATGTTCACATGTAAAGATCTG).
Morpholino injections
Antisense oligonucleotide morpholinos directed against gfra3, ret, artn2, tfap2a and tfap2c were manufactured by GeneTools LLC (Oregon, USA). Morpholinos against gfra3 were designed to the exon 2 donor site (gfra3-2: AGCTCGCTCTTACCCTGTGGAAAGC) and to the exon 4 splice donor site (gfra3-4: GAGGCAGATTTTCTGACCTGCACAG). Perturbation of gfra3 RNA splicing was achieved by co-injection of 1 nl of gfra3-4 (1 mM) and gfra3-2 (0.4 mM) to single-cell stage embryos. Efficacy of morpholino knockdown was assessed by PCR amplification of a 380 bp fragment of gfra3 from cDNA extracted from morphants and control animals, using primers directed to exon 2 and to exon 4 (gfra3-3: GATGCCCAGAACACCTCATG, gfra3-4: AACCTCCGCAGGGCTCGG). Morpholinos against artn2 were designed against sequence immediately 5′ to the start of the open reading frame (artn2-2: TACTCGGCCACCACCAAACTCCCAC). To knock down Artn2 translation, 1.5 nl of artn2-2 (0.2 mM) was injected at the single-cell stage. Ret function was knocked down by injecting 1 nl morpholino ret-1 (0.5 mM) as described previously (Heanue and Pachnis, 2008). Tfap2a and Tfap2c function were knocked down as described by Hoffman et al. (Hoffman et al., 2007).
Cloning and phylogenetic analysis
Full-length sequence for gfra3 (GenBank: HQ401362) was obtained by PCR amplification from cDNA and extended by RACE (BD Biosystems). Zebrafish artn1 and artn2 genes were amplified using published sequence (Hatinen et al., 2007) with the following primers: artn1-f, CATCCCTGGCAGAGGAAGGTGA; artn1-r, AGTCATCGAATCCGTTGGCA; artn2-f, TGAAGATGACCAGCAGCCAGC; arnt2-r, TTCAGCACACCTCATCCCACGC. Sequence comparisons were performed using BLAST; sequences were aligned using CLUSTALX (Thompson et al., 2002) and phylogenetic tree reconstruction performed by Quartet Puzzling using Puzzle (Strimmer and von Haeseler, 1997) or by Bayesian probability using PAUP (Huelsenbeck and Ronquist, 2001).
In situ hybridisation and immunohistochemistry
Riboprobes were synthesised for gfra3, artn1, artn2, ret (Bisgrove et al., 1997; Marcos-Gutierrez et al., 1997), myod (Weinberg et al., 1996), myf5 (Groves et al., 2005), tbx1 (Piotrowski et al., 2003) and capsulin (tcf21) (Knight et al., 2008). Antibodies used for immunohistochemistry were: anti-Myosin (MF20), anti-Engrailed (4D9), anti-Col2a1 (II-II6B3) [all from the Developmental Studies Hybridoma Bank (DSHB), University of Iowa, USA]; anti-GFP (Torrey Pines Laboratories, CA, USA); anti-Phosphohistone-H3 (Merck Biosciences); zns-5 (Zebrafish International Resource Centre, University of Oregon, OR, USA). TUNEL labelling was performed using a POD-conjugated secondary antibody with DAB staining (Roche). Nuclear labelling of cells was achieved using DAPI (Vector Laboratories), muscle was labelled with Alexa-conjugated phalloidin (Invitrogen), cartilage labelled by Alcian Blue and bone detected by Alizarin Red or calcein.
Quantitation of muscle fibre, opercular bone size and cell number
Muscle fibres were labelled by immunohistochemistry and fibres for each dorsal arch muscle counted using Nomarski optics in ten animals for each condition. Standard error of the mean (s.e.m.) was calculated for each dataset and plotted in Excel (Microsoft). TUNEL positive cells and En2-expressing cells were counted in ten mutants and ten wild-type siblings for each stage examined. The area of the opercular bone was measured from light microscopy images using ImageJ (National Institutes of Health). Statistical significance of difference was assessed by applying the Student's t-test using an unpaired two-tailed distribution.
RESULTS
stmhy024 mutants show a highly specific head muscle phenotype
No genes are known to regulate specificity between head muscles during development, as it has proved difficult to separate muscle development from that of the associated skeleton. To identify genes important for regulating head muscle development, we screened for mutants with specific cranial muscle defects that show no cranial skeleton perturbation. stmhy024 mutants had smaller pharyngeal arch muscles, a tightly closed mouth with the lower jaw pointing upwards, but normal cranial skeletal elements (Fig. 1A-F; see Fig. S1A,B in the supplementary material). The muscle phenotype in stmhy024 involves a specific reduction of muscles that attach to the opercular bone (Fig. 1G,H), but the skeleton at the origin (otic skeleton) or insertion (opercular bone) points of these muscles were normal and the opercular bone was not significantly reduced in size (see Table S1 in the supplementary material). To quantify the progression of this opercular muscle phenotype, fibres were counted from dorsal first arch muscles levator arcus palatini (lap) and dilator operculi (do) and from the second arch muscles adductor hyoideous (ah), adductor operculi (ao) and levator operculi (lo), as they are flat and readily amenable to quantification (Edgeworth, 1935). All the dorsal arch muscles showed a normal orientation relative to their insertion or origin and the fibres in the muscles were aligned normally in stmhy024 mutants. However, a specific subset of muscles, including the do, ao and lo, had fewer muscle fibres than the adjacent lap or ah muscles (Fig. 1I; see Table S2 in the supplementary material). The affected muscles (do, ao and lo) all attach to the dorsal aspect of the opercular bone. The superior hyohyoideus (hh sup) muscle attaches to the opercular bone from the ventral second arch and was always absent in stmhy024 mutants (Fig. 1C,D). Muscle defects in stmhy024 could arise as a result of changes in the identity of the muscle type. In stmhy024 mutants slow and fast myosin distribution appeared normal, despite a reduction of fibre number in the opercular muscles (see Fig. S1C-J in the supplementary material). Early muscle identity is likewise unaffected in stmhy024 as expression of En2 in dorsal first arch muscle precursors was unaffected prior to muscle formation (Fig. 3K,L; see Fig. S1K,L in the supplementary material). Therefore, the specific opercular muscle phenotype in stmhy024 is not due to skeletal abnormalities or alterations to muscle identity and reveals that head muscle development is regulated in a modular manner, independent of muscle origin from a particular pharyngeal arch.
Musculoskeletal labelling of stmhy024 zebrafish mutants reveals specific muscle defects. (A-D) Immunolabelling of muscle (red) and cartilage (green) reveals that stmhy024 mutants (B,D) have reduced dilator operculi (do), adductor operculi (ao), levator operculi (lo) and hyohyoideus superiores (hh sup) muscles (arrowheads) relative to wild type (WT; A,C). e, eye. (E,F) stmhy024 mutants (F) have tightly closed mouths (arrow) relative to WT (E). (G,H) Higher magnification views of dorsal pharyngeal arch muscles reveal that the do, ao and lo attaching to the opercular bone (op, green) are reduced in stmhy024; the non-opercular muscles levator arcus palatini (lap) and adductor hyoideous (ah) are unaffected. (I) Quantification of fibre number in dorsal arch muscles (mean ± s.e.m.) reveals a specific and significant reduction (*P<0.0001) of the opercular muscles in stmhy024 relative to WT (n=10), during muscle development at 72, 96 and 120 hours post-fertilisation (hpf). Scale bars: 100 μm in A-D; 50 μm in G,H.
Musculoskeletal labelling of stmhy024 zebrafish mutants reveals specific muscle defects. (A-D) Immunolabelling of muscle (red) and cartilage (green) reveals that stmhy024 mutants (B,D) have reduced dilator operculi (do), adductor operculi (ao), levator operculi (lo) and hyohyoideus superiores (hh sup) muscles (arrowheads) relative to wild type (WT; A,C). e, eye. (E,F) stmhy024 mutants (F) have tightly closed mouths (arrow) relative to WT (E). (G,H) Higher magnification views of dorsal pharyngeal arch muscles reveal that the do, ao and lo attaching to the opercular bone (op, green) are reduced in stmhy024; the non-opercular muscles levator arcus palatini (lap) and adductor hyoideous (ah) are unaffected. (I) Quantification of fibre number in dorsal arch muscles (mean ± s.e.m.) reveals a specific and significant reduction (*P<0.0001) of the opercular muscles in stmhy024 relative to WT (n=10), during muscle development at 72, 96 and 120 hours post-fertilisation (hpf). Scale bars: 100 μm in A-D; 50 μm in G,H.
Positional cloning of stmhy024. (A) stmhy024 maps to a 0.2 cM region on chromosome 14:32.1 between simple sequence length polymorphisms (SSLPs) z1812 and z28668. SSLPs used for mapping are coloured with arrows indicating orientation relative to the stmhy024 locus; coloured numbers show the number of recombinants from 1000 meioses. (B) A maximum likelihood tree of vertebrate Gfra genes reveals that stmhy024 encodes a zebrafish gfra3 orthologue (red box). Branch lengths represent maximum likelihood distances and values at node indicate support. Trees generated by Bayesian probability produced a similar topology (not shown). Protein sequences used for tree construction include Gfra1, Gfra2, Gfra3 and Gfra4 from human (hs), chicken (gg) and zebrafish (dr). (C,D) Sequence traces from gfra3 transcripts amplified from homozygote wild type (WT+/+), heterozygote (WT+/−) and stmhy024 reveal that a 26 bp deletion occurs at the exon 4 splice acceptor site (C). This causes a frameshift and results in a truncated protein possessing domain D1 but lacking domains D2 and D3 plus the GPI anchor signal (D).
Positional cloning of stmhy024. (A) stmhy024 maps to a 0.2 cM region on chromosome 14:32.1 between simple sequence length polymorphisms (SSLPs) z1812 and z28668. SSLPs used for mapping are coloured with arrows indicating orientation relative to the stmhy024 locus; coloured numbers show the number of recombinants from 1000 meioses. (B) A maximum likelihood tree of vertebrate Gfra genes reveals that stmhy024 encodes a zebrafish gfra3 orthologue (red box). Branch lengths represent maximum likelihood distances and values at node indicate support. Trees generated by Bayesian probability produced a similar topology (not shown). Protein sequences used for tree construction include Gfra1, Gfra2, Gfra3 and Gfra4 from human (hs), chicken (gg) and zebrafish (dr). (C,D) Sequence traces from gfra3 transcripts amplified from homozygote wild type (WT+/+), heterozygote (WT+/−) and stmhy024 reveal that a 26 bp deletion occurs at the exon 4 splice acceptor site (C). This causes a frameshift and results in a truncated protein possessing domain D1 but lacking domains D2 and D3 plus the GPI anchor signal (D).
A mutation in a GDNF family receptor causes the stm phenotype
Positional cloning was used to map stmhy024 to a region of chromosome 14 containing a Gfra gene (Fig. 2A) and confirmed using a radiation hybrid panel (see Fig. S2A in the supplementary material). Phylogenetic analysis revealed that it is an orthologue of amniote Gfra3 genes (Fig. 2B). Sequencing of gfra3 transcripts from stmhy024 mutants revealed a 26 bp deletion in the open reading frame, causing a frame shift and premature stop codon (Fig. 2C). This deletion is due to a guanosine-to-adenosine transition at the intron 3-exon 4 splice site, resulting in loss of the canonical splice acceptor with a cryptic splice site in exon 4 used instead. The mutated Gfra3 protein in stmhy024 mutants possesses only extracellular domain 1 but lacks domains D2 and D3 necessary for binding GDNF family ligands (Fig. 2D). To confirm that a loss of Gfra3 function caused the muscle phenotype, gfra3 splicing was disrupted by injection of antisense morpholino oligonucleotides. gfra3 morphants had tightly closed mouths at 5 days post-fertilisation (dpf) and showed statistically significant reductions of the do, ao and lo muscles relative to uninjected control animals at 80 hpf (P<0.0001), but other adjacent head muscles were not affected (see Fig. S2B; Table S3 in the supplementary material). Interestingly, the muscle phenotype in gfra3 morphants started to recover by later stages of development (144 hpf) and RT-PCR of gfra3 from morphants and controls at different stages showed that an attenuation of morpholino function occurred at this point (see Fig. S2C in the supplementary material). This recovery of muscle development in gfra3 morphants contrasts with stmhy024 mutants that never recovered to the same extent and highlights a constant requirement for Gfra3 function during opercular muscle development.
stmhy024 mutants show myogenic defects specifically in opercular muscles. (A-H) In situ hybridisation with tbx1 (A,B) and capsulin (C,D) probes reveals that muscle specification is unaffected in the pharyngeal arch muscle precursors of stmhy024. However, both myf5 (E,F) and myod (G,H) expression are reduced in stmhy024 relative to wild type (WT). Arrowheads indicate muscle primordia. (I-L) Fluorescent in situ reveals that myod expression is reduced specifically in the precursors of the lo and ao at 52 hours post-fertilisation (hpf; I,J) but is unaffected in the adjacent ah. At later stages, there are fewer En2-expressing (En2+) muscle cells specifically in the do but not the lap of stmhy024 (K,L). Brackets indicate do muscle cell nuclei. (M) Quantification of En2+ muscle precursors in stmhy024 (blue) and WT (red) at 48, 52 and 56 hpf reveals that stmhy024 mutants have fewer muscle precursor cells than WT in the lap or do primordia from 56 hpf (mean ± s.e.m.). Pharyngeal arches 1-7 are shown by numbering in A-F. ah, adductor hyoideous; ao, adductor operculi; do, dilator operculi; e, eye; lap, levator arcus palatini; lo, levator operculi. Scale bars: 50 μm in A-H,K-L; 20 μm in I,J.
stmhy024 mutants show myogenic defects specifically in opercular muscles. (A-H) In situ hybridisation with tbx1 (A,B) and capsulin (C,D) probes reveals that muscle specification is unaffected in the pharyngeal arch muscle precursors of stmhy024. However, both myf5 (E,F) and myod (G,H) expression are reduced in stmhy024 relative to wild type (WT). Arrowheads indicate muscle primordia. (I-L) Fluorescent in situ reveals that myod expression is reduced specifically in the precursors of the lo and ao at 52 hours post-fertilisation (hpf; I,J) but is unaffected in the adjacent ah. At later stages, there are fewer En2-expressing (En2+) muscle cells specifically in the do but not the lap of stmhy024 (K,L). Brackets indicate do muscle cell nuclei. (M) Quantification of En2+ muscle precursors in stmhy024 (blue) and WT (red) at 48, 52 and 56 hpf reveals that stmhy024 mutants have fewer muscle precursor cells than WT in the lap or do primordia from 56 hpf (mean ± s.e.m.). Pharyngeal arches 1-7 are shown by numbering in A-F. ah, adductor hyoideous; ao, adductor operculi; do, dilator operculi; e, eye; lap, levator arcus palatini; lo, levator operculi. Scale bars: 50 μm in A-H,K-L; 20 μm in I,J.
Gfra3 function is required for myogenesis but not for muscle specification
The specific opercular muscle defect in stmhy024 mutants might result from a perturbation of myogenic specification. The earliest specifiers of head muscle identity (tbx1, capsulin) are unaffected in stmhy024 mutants (Fig. 3A-D). By contrast, expression of the MRF gene myf5 was reduced in the second arch of stmhy024 at similar stages (Fig. 3E,F). At later stages of head muscle development, myf5 was no longer expressed in the pharyngeal arches of WT animals or stmhy024 mutants (data not shown). Another MRF, myod, is expressed at stages when pharyngeal arch muscles start differentiating and express muscle structural proteins (Lin et al., 2006). myod was specifically reduced in the dorsal first and second arches of stmhy024 (Fig. 3G,H) and labelling of myod transcripts revealed an obvious reduction in the muscle precursors of the ao and lo, but not in the ah, a non-opercular dorsal second arch muscle (Fig. 3I,J). This specific reduction of myod in ao and lo, but not ah, precursors reflects subsequent reductions of these muscles and suggests that Gfra3 is needed for normal muscle differentiation in opercular muscles, but not in adjacent non-opercular muscles. Prior to muscle differentiation, En2, a marker of dorsal first arch muscle precursors, was expressed normally in stmhy024 mutants, but by 72 hpf it was reduced specifically in the do and not the lap (Fig. 3K,L). In order to quantify myogenic defects in stmhy024, the number of muscle precursors expressing En2 (En2+) was evaluated throughout head muscle development. There was a significant reduction in En2+ myoblasts in stmhy024 compared with WT from 56 hpf, but not at earlier stages (Fig. 3M). This reduction of En2+ muscle precursors corresponds to the stage at which myod expression was obviously reduced in muscle anlagen of stmhy024. Changes to the expression of myod and En2 could be due to cell death or changes to cell proliferation in muscle cells. TUNEL labelling of apoptotic cells revealed no statistically significant increase of cell death in the pharyngeal arches of stmhy024 at any stage of muscle differentiation (see Fig. S2D in the supplementary material). Phosphohistone-H3 protein labelling of cells in the G2 to mitosis transition showed that En2+ muscle precursors of the lap and do rarely proliferated at 48 hpf, when differentiation starts, and that this did not change in stmhy024 despite a reduction in the number of En2+ cells (see Fig. S2E-J in the supplementary material). Gfra3 function, therefore, appears to be necessary for myogenic differentiation, as cell death or proliferation did not change in the arches of stmhy024, the number of En2+ muscle cells failed to increase and myod expression was reduced in forming opercular muscles.
gfra3 and artn2 show tissue-specific expression in an opercular complex. (A,B) gfra3 (purple) is expressed in pharyngeal mesoderm at 30 hours post-fertilisation (hpf; A) and in muscle precursors (arrowhead) with En2 (brown, B). (C) At 50 hpf, gfra3 is expressed in forming muscle fibres expressing GFP (brown) in alpha-actin:GFP animals and associated cells. (D,D′) Fluorescent in situ of myod (green) and gfra3 (red) reveals colocalisation (yellow) in all forming pharyngeal arch muscles, but not in fin or ocular muscles. A transverse section (indicated by the line in D) through the second arch reveals gfra3 expression in myod− cells (D′). Red and green arrowheads indicate gfra3+myod– and gfra3+myod+ cells, respectively. (E,E′) At stages when primary muscle fibres have formed (120 hpf), sagittal sections show that gfra3 is expressed in mesenchymal cells adjacent to muscle fibres (brown, E) that completely surround the forming lo muscle (E'). Line in E indicates level of section in E′. (F-I″) In situ hybridisation shows that artn2 is expressed in mesenchyme of the pharyngeal arches from 30 hpf. Transverse (F′,F″) and sagittal (G) sections of the arches (1,2), reveal that artn2 expression is restricted to mesenchymal cells (arrowheads) and is excluded from the pharyngeal pouches (pp). Subsequently, artn2 becomes restricted to discrete domains in the dorsal first and second arches at 50 hpf (H). Sagittal (I) and transverse (I′,I″) sections reveal that as muscle fibres form (brown), artn2 expression is adjacent to the forming opercular muscles. Lines in I indicate level of sections in I′ and I″. Pharyngeal arches 1-7 are shown by numbering. ao, adductor operculi; do, dilator operculi; e, eye; lap, levator arcus palatini; lo, levator operculi. Scale bars: 100 μm in A,D,E′,F,I′,I″; 20 μm in B,C,D′,E,F′-I.
gfra3 and artn2 show tissue-specific expression in an opercular complex. (A,B) gfra3 (purple) is expressed in pharyngeal mesoderm at 30 hours post-fertilisation (hpf; A) and in muscle precursors (arrowhead) with En2 (brown, B). (C) At 50 hpf, gfra3 is expressed in forming muscle fibres expressing GFP (brown) in alpha-actin:GFP animals and associated cells. (D,D′) Fluorescent in situ of myod (green) and gfra3 (red) reveals colocalisation (yellow) in all forming pharyngeal arch muscles, but not in fin or ocular muscles. A transverse section (indicated by the line in D) through the second arch reveals gfra3 expression in myod− cells (D′). Red and green arrowheads indicate gfra3+myod– and gfra3+myod+ cells, respectively. (E,E′) At stages when primary muscle fibres have formed (120 hpf), sagittal sections show that gfra3 is expressed in mesenchymal cells adjacent to muscle fibres (brown, E) that completely surround the forming lo muscle (E'). Line in E indicates level of section in E′. (F-I″) In situ hybridisation shows that artn2 is expressed in mesenchyme of the pharyngeal arches from 30 hpf. Transverse (F′,F″) and sagittal (G) sections of the arches (1,2), reveal that artn2 expression is restricted to mesenchymal cells (arrowheads) and is excluded from the pharyngeal pouches (pp). Subsequently, artn2 becomes restricted to discrete domains in the dorsal first and second arches at 50 hpf (H). Sagittal (I) and transverse (I′,I″) sections reveal that as muscle fibres form (brown), artn2 expression is adjacent to the forming opercular muscles. Lines in I indicate level of sections in I′ and I″. Pharyngeal arches 1-7 are shown by numbering. ao, adductor operculi; do, dilator operculi; e, eye; lap, levator arcus palatini; lo, levator operculi. Scale bars: 100 μm in A,D,E′,F,I′,I″; 20 μm in B,C,D′,E,F′-I.
gfra3 is expressed in pharyngeal arch muscles
To understand how Gfra3 functions to promote opercular muscle differentiation, its expression was characterised relative to head muscle development. gfra3 expression was observed in the pharyngeal arches from 20 hpf (data not shown) and colocalised with En2+ muscle precursors of the lap and do at 30 hpf (Fig. 4A,B). Expression persisted in the arches at the onset of muscle differentiation and colocalised with an alpha-actin:GFP transgene (Higashijima et al., 1997) expressed in differentiating muscle cells (Fig. 4C) and with myod in all forming pharyngeal arch muscles, including the lateral rectus (Fig. 4D). Transverse sections showed that adjacent non-myod-expressing cells in the second pharyngeal arch express gfra3, revealing that gfra3 is in both differentiating muscle cells and other non-differentiating cells of the pharyngeal arches (Fig. 4D′). As muscle cells differentiate and form fibres, gfra3 persisted in cells surrounding the maturing muscle fibres (Fig. 4E,E′). Many of these gfra3+ cells showed an elongated morphology characteristic of immature myofibres and expressed gfra3 at stages when the muscles start to function in opening and closing of the jaw. In stmhy024 mutants, gfra3 expression was mostly lost in the pharyngeal arches, potentially owing to nonsense-mediated decay (see Fig. S2K,L in the supplementary material). Similarly, gfra3 expression was reduced in the arches of gfra3 morphants (see Fig. S2M,N in the supplementary material). gfra3 is, therefore, expressed in both muscle precursors and surrounding mesenchymal cells from early stages and continues to be expressed as muscle differentiation occurs.
A Gfra3 ligand, Artn2, is required for opercular muscle development
Mammalian Gfra3 receptors are specifically bound and activated by Artn ligands (Baloh et al., 1998). The ligand binding site of zebrafish Gfra3 possesses the same conserved residues for Artn binding as mammalian orthologues, suggesting that it shows similar specificity during ligand binding (Wang et al., 2006; Hatinen et al., 2007). Zebrafish have two artn genes and the residues necessary for Gfra3 binding are conserved with mammalian Artn proteins (Hatinen et al., 2007). Expression of artn1 and artn2 was assessed to determine whether they could be potential activators of Gfra3 during opercular muscle development. artn1 was never expressed in cells of the pharyngeal arches (data not shown). By contrast, artn2 was restricted to mesenchymal cells of the pharyngeal arches (Fig. 4F) and was present in ventral cells of the arches where cells derived from the cranial neural crest (CNC) lie (Fig. 4F′,F″), but expression was absent from the pharyngeal pouches (Fig. 4G). At the onset of myogenic differentiation, artn2 was expressed in cells overlying the do and overlying the ao and lo muscles (Fig. 4H) and persisted in mesenchymal cells adjacent to forming opercular muscles (Fig. 4I-I″). artn2 expression in cells adjacent to forming gfra3+ opercular muscles make it a good candidate for activating Gfra3 during head muscle development. Knockdown of artn2 function resulted in specific reductions of the opercular muscles do, ao and lo, but adjacent non-opercular muscles lap and ah were not significantly affected (see Table S4 in the supplementary material). The associated skeleton and opercular bone were not affected in artn2 morphants, revealing a requirement for Artn2 function during opercular muscle development but not for skeletal development (Fig. 5A-D).
Loss of Ret or Artn2 function results in specific opercular muscle defects. (A-D,H-M) Immunolabelling of cartilage, bone (green) and muscles (red) of uninjected controls (A,C), artn2 morphants (B,D), wild type (WT; H,J,L) and rethu2846 mutants (I,K,M) at 120 hours post-fertilisation (hpf). Specific reductions of the do, ao, lo and hh sup muscles occur in artn2 morphants and rethu2846 mutants, but the lap and ah muscles are unaffected. (E-G) rethu2846 mutants have a tightly closed mouth (G, arrowhead) relative to WT (F) and have a point mutation in codon 229 (T>A) of exon 4 in the ret gene that changes a cysteine to a stop codon in the coding sequence (E). This results in a truncated protein lacking the tyrosine kinase domain (red), the transmembrane region (green) and part of the extracellular domain (blue). A morpholino directed to the exon 1 splice donor site (retSp) causes aberrant splicing of ret. ah, adductor hyoideous; ao, adductor operculi; do, dilator operculi; e, eye; hh sup, hyohyoideus superiores; lap, levator arcus palatini; lo, levator operculi. Scale bars: 100 μm in A,B,H-K; 50 μm in C,D,L,M.
Loss of Ret or Artn2 function results in specific opercular muscle defects. (A-D,H-M) Immunolabelling of cartilage, bone (green) and muscles (red) of uninjected controls (A,C), artn2 morphants (B,D), wild type (WT; H,J,L) and rethu2846 mutants (I,K,M) at 120 hours post-fertilisation (hpf). Specific reductions of the do, ao, lo and hh sup muscles occur in artn2 morphants and rethu2846 mutants, but the lap and ah muscles are unaffected. (E-G) rethu2846 mutants have a tightly closed mouth (G, arrowhead) relative to WT (F) and have a point mutation in codon 229 (T>A) of exon 4 in the ret gene that changes a cysteine to a stop codon in the coding sequence (E). This results in a truncated protein lacking the tyrosine kinase domain (red), the transmembrane region (green) and part of the extracellular domain (blue). A morpholino directed to the exon 1 splice donor site (retSp) causes aberrant splicing of ret. ah, adductor hyoideous; ao, adductor operculi; do, dilator operculi; e, eye; hh sup, hyohyoideus superiores; lap, levator arcus palatini; lo, levator operculi. Scale bars: 100 μm in A,B,H-K; 50 μm in C,D,L,M.
Ret is required for opercular muscle development
Many of the biological actions of the mammalian Gfra receptors are mediated through the Ret tyrosine kinase receptor (Airaksinen and Saarma, 2002). The specific requirements for Gfra3 and Artn2 during opercular muscle development might reflect a general requirement for Ret function during head muscle development. To test whether Ret function is required for head muscle development, a zebrafish ret mutant was identified through a TILLING screen. The rethu2846 mutant has a stop codon in exon 4 of ret that results in a prematurely truncated protein possessing part of the extracellular domain, but lacking the transmembrane domain or the intracellular tyrosine kinase domain essential for signalling (Fig. 5E). rethu2846 mutants had a tightly closed mouth but showed no obvious defects in their cranial skeleton (Fig. 5F-M). Quantification of muscle fibres in rethu2846 mutants revealed that there is a specific reduction of opercular muscles, but not of adjacent non-opercular muscles (see Table S5 in the supplementary material). To confirm that the specific opercular muscle defects are due to a loss of Ret function, animals were injected by a morpholino (retSp) to knock down expression of ret mRNA (Heanue and Pachnis, 2008). ret morphants showed the same specific opercular muscle reductions as rethu2846 mutants (see Table S6 in the supplementary material).
Ret colocalises with Gfra3 in opercular muscle precursor cells
Zebrafish ret was expressed in the pharyngeal arches from 20 hpf in cells that lie medially within the arch (Fig. 6A-B). To determine whether ret+ cells in the forming opercular muscles are of CNC origin, ret expression at 32 hpf was compared with GFP+ CNC cells in the arches of sox10:GFP transgenic fish (Wada et al., 2005). There was no co-expression of ret with GFP in the arches; rather the ret expression was located in a central core of cells surrounded by GFP+ CNC-derived cells (Fig. 6C-C″). Mesoderm becomes surrounded by CNC in the arches in a similar manner, suggesting that the ret+ cells are mesodermal (Kimmel et al., 2001). ret was expressed in myoblasts of the dorsal first arch expressing En2, revealing these ret+ cells are myogenic precursor cells (Fig. 6D). To determine whether ret is expressed in CNC at stages when head muscle differentiation occurs, ret expression was compared with GFP in fli1:GFP transgenic fish, where it is strongly expressed in CNC and its skeletogenic derivatives in the pharyngeal arches (Crump et al., 2006). There was no ret expression in CNC-derived GFP+ cells of the pharyngeal arches in fli1:GFP fish at 55 hpf, when myogenic differentiation occurs, suggesting that the ret+ cells in the muscle are not CNC-derived (see Fig. S3C,C′ in the supplementary material). Potentially, ret is expressed in CNC-derived cells that do not express GFP in either fli1:GFP or sox10:GFP; therefore, ret expression was assessed in animals lacking CNC caused by knockdown of Tfap2a and Tfap2c function (Hoffman et al., 2007). In tfap2a tfapc morphants ret was still expressed in the pharyngeal arches, revealing that the majority of ret+ cells in the arches were not CNC (see Fig. S3A,B in the supplementary material). As development proceeded, ret expression became more restricted to the forming opercular muscles (Fig. 6E). The majority of ret expressing cells did not express myod and were restricted to the periphery of the muscle, suggesting that most ret+ cells were not differentiating (Fig. 6F,F′). gfra3 was expressed in both myod+ differentiating muscle cells and myod− cells in the arches (Fig. 4D′). gfra3 and ret colocalised in cells adjacent to the forming opercular muscles, with cells interspersed within the muscles of the ao, lo and do (Fig. 6G,G′). Colocalisation of ret and gfra3 was strongest in the precursors of the ao and lo opercular muscles, but was absent from the non-opercular ah muscle (Fig. 6G″). Differentiating muscle fibres expressing alpha-actin:GFP did not express ret, but ret+ cells were closely associated with them (Fig. 6H). As muscle formation proceeded, ret+ cells became localised to the opercular muscles (do, ao, lo and hyohyoideus), but not the non-opercular muscles lap or ah (Fig. 6I). Transverse sections revealed that these ret+ cells were closely associated with fibres in the forming opercular muscles, but ret was not expressed in muscle fibres (Fig. 6J). In summary, ret was expressed in mesodermal cells and not CNC of the arches, was then excluded from differentiating myoblasts and became restricted to cells in the forming opercular muscles. During muscle differentiation ret colocalised with an activating Gfra3 co-receptor and Ret loss of function resulted in the same specific reduction of opercular muscles as in animals lacking Gfra3 and Artn2 function. It is the opercular muscles that contain ret+gfra3+ cells and not adjacent non-opercular muscles, highlighting a potential manner in which Ret can act specifically during myogenesis.
ret expression becomes restricted to cells associated with opercular muscles. (A-B) ret is expressed in the first (1) and second (2) arches at 25 hours post-fertilisation (hpf; A, white arrowheads); transverse section through the arch (A′) reveals that ret+ cells (black arrowhead) lie medially. ret becomes restricted to medial cells of the arches at 30 hpf (B) relative to GFP+ cells in sox10:GFP animals (C). (C-D) Confocal sections reveal that ret+ cells are surrounded by GFP+ cells (C′) and transverse sections fail to show colocalisation of ret and GFP (C″). At similar stages, ret expression is detected in myoblasts of the first arch that show En2 immunoreactivity (D). (E) ret expression in the arches becomes restricted to discrete populations of cells, including some associated with the developing opercular muscles (arrowheads). (F,F′) ret and myod do not appear to be expressed in the same cells of the opercular muscles (F) and transverse sections fail to show colocalisation (F′). (G-G″) ret and gfra3 are both expressed in opercular muscles at 55 hpf (G) and transverse sections (G′) and ventral views (G″) show that they colocalise in the ao and lo, but not in the ah. (H) Differentiating muscle fibres (brown) in alpha-actin:GFP fish do not express ret (blue) at 55 hpf, but ret+ cells lie adjacent to fibres (arrowheads). (I,J) Lateral view of the arches in 72 hpf embryos following in situ hybridisation and immunolabelling (I) shows that ret expressing cells (blue) are associated with the forming do, ao and lo muscles (brown). Transverse sections reveal that ret is expressed in cells of the do but not the lap (J) at this stage. Lines in C, F and G indicate the level of section in C″, F′ and G′, respectively. yz and xz planes are shown for C′, C″, D and F′. ah, adductor hyoideous; ao, adductor operculi; do, dilator operculi; e, eye; lap, levator arcus palatini; lo, levator operculi. Pharyngeal arches 1-7 are shown by numbering in A-C. Scale bars: 100 μm in A-C,E,G,J; 20 μm in A′,C′,C″,F,F′,G′-I; 10 μm in D.
ret expression becomes restricted to cells associated with opercular muscles. (A-B) ret is expressed in the first (1) and second (2) arches at 25 hours post-fertilisation (hpf; A, white arrowheads); transverse section through the arch (A′) reveals that ret+ cells (black arrowhead) lie medially. ret becomes restricted to medial cells of the arches at 30 hpf (B) relative to GFP+ cells in sox10:GFP animals (C). (C-D) Confocal sections reveal that ret+ cells are surrounded by GFP+ cells (C′) and transverse sections fail to show colocalisation of ret and GFP (C″). At similar stages, ret expression is detected in myoblasts of the first arch that show En2 immunoreactivity (D). (E) ret expression in the arches becomes restricted to discrete populations of cells, including some associated with the developing opercular muscles (arrowheads). (F,F′) ret and myod do not appear to be expressed in the same cells of the opercular muscles (F) and transverse sections fail to show colocalisation (F′). (G-G″) ret and gfra3 are both expressed in opercular muscles at 55 hpf (G) and transverse sections (G′) and ventral views (G″) show that they colocalise in the ao and lo, but not in the ah. (H) Differentiating muscle fibres (brown) in alpha-actin:GFP fish do not express ret (blue) at 55 hpf, but ret+ cells lie adjacent to fibres (arrowheads). (I,J) Lateral view of the arches in 72 hpf embryos following in situ hybridisation and immunolabelling (I) shows that ret expressing cells (blue) are associated with the forming do, ao and lo muscles (brown). Transverse sections reveal that ret is expressed in cells of the do but not the lap (J) at this stage. Lines in C, F and G indicate the level of section in C″, F′ and G′, respectively. yz and xz planes are shown for C′, C″, D and F′. ah, adductor hyoideous; ao, adductor operculi; do, dilator operculi; e, eye; lap, levator arcus palatini; lo, levator operculi. Pharyngeal arches 1-7 are shown by numbering in A-C. Scale bars: 100 μm in A-C,E,G,J; 20 μm in A′,C′,C″,F,F′,G′-I; 10 μm in D.
Gfra3 function is required for maintaining ret expression in opercular associated cells. (A-H) Expression of gfra3 (A,B), artn2 (C,D) and ret (E-H) in rethu2846 mutants (B,D) and wild-type (WT) siblings (A,C), stmhy024 mutants (F,H) and WT siblings (E,G) at 32 hours post-fertilisation (hpf; E,F) or 55 hpf (A-D,G,H). At 55 hpf, there are fewer gfra3-expressing cells in the forming adductor operculi (ao) and levator operculi (lo) (arrowheads) of rethu2846 mutants (B) compared with WT (A). By contrast, artn2 expression in the dorsal pharyngeal arches is unaffected in rethu2846 mutants (D) compared with WT (C). At 32 hpf, there are fewer ret+ cells (black arrowheads) in the dorsal second arch of stmhy024 mutants (F) relative to WT (E). Later, at 55 hpf ret expression in the opercular muscles is lost, but is unaffected in the anterior lateral line ganglia (white arrowhead, H). (I) A model for Ret signalling during opercular muscle development. Ret receptor and the Gfra3 co-receptor are present on myoblast cells (red). Artn2 from adjacent mesenchymal cells (blue) binds the Gfra3 co-receptor in Ret+ cells and muscle cells. Activation of Ret signalling by Gfra3 and Artn2 is required to maintain ret expression in myoblast cells and for myogenic differentiation to occur, involving myod expression and a loss of ret expression. Scale bars: 100 μm.
Gfra3 function is required for maintaining ret expression in opercular associated cells. (A-H) Expression of gfra3 (A,B), artn2 (C,D) and ret (E-H) in rethu2846 mutants (B,D) and wild-type (WT) siblings (A,C), stmhy024 mutants (F,H) and WT siblings (E,G) at 32 hours post-fertilisation (hpf; E,F) or 55 hpf (A-D,G,H). At 55 hpf, there are fewer gfra3-expressing cells in the forming adductor operculi (ao) and levator operculi (lo) (arrowheads) of rethu2846 mutants (B) compared with WT (A). By contrast, artn2 expression in the dorsal pharyngeal arches is unaffected in rethu2846 mutants (D) compared with WT (C). At 32 hpf, there are fewer ret+ cells (black arrowheads) in the dorsal second arch of stmhy024 mutants (F) relative to WT (E). Later, at 55 hpf ret expression in the opercular muscles is lost, but is unaffected in the anterior lateral line ganglia (white arrowhead, H). (I) A model for Ret signalling during opercular muscle development. Ret receptor and the Gfra3 co-receptor are present on myoblast cells (red). Artn2 from adjacent mesenchymal cells (blue) binds the Gfra3 co-receptor in Ret+ cells and muscle cells. Activation of Ret signalling by Gfra3 and Artn2 is required to maintain ret expression in myoblast cells and for myogenic differentiation to occur, involving myod expression and a loss of ret expression. Scale bars: 100 μm.
Ret signalling is mediated through Gfra3 in the pharyngeal arches
The same highly specific muscle phenotypes observed after loss of Gfra3, Artn2 and Ret function implies that they are functioning in the same pathway. To determine whether this is due to regulation of one gene by another, their expression was analysed in animals lacking functional Gfra3, Ret or Artn2. At early stages of myogenesis gfra3 expression was unaffected in rethu2846 mutants (data not shown); during muscle differentiation, gfra3 was expressed at similar levels as in WT, but there appeared to be slightly fewer gfra3+ cells in the ao and lo muscles (Fig. 7A,B). artn2 expression was normal in rethu2846 mutants at both early (data not shown) and later stages of myogenesis (Fig. 7C,D). Ret signalling is, therefore, not required for regulating the level of gfra3 or artn2 expression during myogenesis, but might be necessary for ensuring an appropriate number of gfra3+ cells. In stmhy024 mutants, early ret expression in the dorsal second arch was reduced at 32 hpf (Fig. 7E,F) and expression was lost in the opercular-associated cells during muscle differentiation; by contrast, expression was unaffected in the nearby anterior and posterior lateral line ganglia (Fig. 7G,H). Potentially, this could be due to a loss of muscle-associated cells, such as connective cells. Labelling of bone and connective cells revealed no obvious perturbations in rethu2846 mutants, and two connective cell markers, tenascin C and tenascin W, continued to be expressed in cells connecting the ao and lo muscles to the opercular bone and other opercular-associated cells in rethu2846 and stmhy024 mutants (see Fig. S3D-M in the supplementary material). Thus, ret expression in the arches is dependent on Gfra3 at later stages of myogenesis and loss of ret expression in stmhy024 mutants is not due to a failure of connective cells to form at the opercular bone.
DISCUSSION
The molecular mechanisms that dictate specific muscle shape and size during development remain elusive. In this study, we identify a highly specific requirement for Ret signalling during the formation of a subset of functionally related head muscles. Expression of ret, artn2 and gfra3 is coordinated in cells associated with opercular muscles and differentiation of these muscles requires function of all three genes. Strikingly, only opercular muscles and not adjacent non-opercular muscles require Ret signalling for their development and this correlates with the restriction of ret+ cells to opercular muscles. This suggests that muscles and their associated tissues are coordinated as discrete modules during musculoskeletal development and that Ret signalling is needed for the development of a specific subset of muscles.
Coordinated activation of Ret drives the development of a subset of head muscles
Animals lacking Artn2, Gfra3 and Ret function all show the same, highly specific opercular muscle defect, implying that they are acting in the same pathway. The muscle defects correlate with the highly restricted expression of artn2 and ret in cells that form a complex involving the opercular muscles. Gfra3 loss of function results only in opercular muscle defects despite expression of gfra3 in other muscles. As gfra3 is the only Gfra receptor expressed in cells adjacent to and in head muscles during muscle differentiation (data not shown), it is likely that Ret activation requires Gfra3 function. The highly restricted expression of ret in differentiating opercular muscles correlates directly with the specific nature of the muscle phenotype caused by loss of Ret function. This suggests that Ret signalling is activated specifically only in the opercular muscles and occurs by a restriction of Ret to a subset of cells in them. The modular nature of the muscle phenotype in Ret mutants is unexpected, as it involves muscles derived from different pharyngeal arches that connect to the opercular bone. Adjacent muscles derived from the same muscle anlagen, appear normal in Ret signalling mutants. This reflects the restriction of ret+ cells to opercular muscles and suggests that these muscles have a distinct identity involving Ret signalling that is independent of their origin from a particular arch.
In the head, muscle connective cells are derived from CNC (Noden, 1983; Couly et al., 1992) and perturbations to the CNC can cause both skeletal and muscle defects (Rinon et al., 2007). The ret+ opercular cells might be CNC-derived, suggesting that Ret is functioning in muscle connective cells. However, ret+ cells in the forming muscles do not co-express GFP in fli1:GFP or sox10:GFP transgenic fish, suggesting that they are not CNC-derived. Ablation of CNC did not result in a loss of ret expression, and ret is expressed in En2+ myoblasts of the dorsal first arch. ret appears to be expressed in mesodermal cells, and subsequently myoblasts, in the arches. Subsequently, the majority of ret+ cells do not express myod or alpha-actin:GFP, markers for differentiating muscle cells, but ret is expressed with gfra3 in cells of the ao, lo and do. Potentially the ret+gfra3+ cells are a secondary population of muscle cells that contribute to growth of the muscles after the primary muscle fibres have formed, similar to that in the dermomyotome (Devoto et al., 2006). These possibilities could be resolved by lineage analysis of the ret+ opercular-associated cells.
Ret signalling promotes muscle differentiation
All muscles require MRF function for their differentiation (Buckingham, 2006). Our findings suggest that Ret is able to regulate differentiation specifically in opercular muscles through a regulation of MRF genes. Muscle specification is normal in an absence of Ret signalling as myoblasts express tbx1 and caps as normal. Both myf5 and myod expression are reduced in the pharyngeal arches of rethu2846 and stmhy024 mutants, revealing a role for Ret during myogenesis. As muscle differentiation commences, Ret is required specifically for normal myod expression and muscle fibre formation in opercular muscles, but not in adjacent non-opercular muscles, despite their origin from the same precursors in the arch. How Ret signalling can regulate myogenesis in opercular muscle cells is not clear. However, given that ret is expressed in myoblasts at earlier stages, Ret signalling might act to regulate myogenic progression. The reduction of early myf5 expression in stmhy024 mutants suggests that Ret signalling is needed continuously for myogenesis; the recovery of muscle in gfra3 morphants supports a late role of Ret signalling during muscle formation. Based on our results, we propose a model for how Ret signalling can regulate myogenesis in opercular muscles (Fig. 7I). Artn2 binding to Gfra3 causes activation of Ret in myoblast precursors. Active Ret signalling is required for maintaining ret expression in these cells and for regulating subsequent myogenesis. As the majority of myoblasts do not co-express ret and myod, one implication of this model is that ret expression is lost in differentiating myoblasts. The role of Ret signalling in modulating myogenesis in precursor cells for a subset of muscles thus provides a mechanism for coordinating the size and development of a certain muscles, but not adjacent muscles.
Evolution of an opercular muscle scaffold
It is intriguing that all the muscles requiring Ret signalling for their development attach to the opercular bone and so are functionally related. In zebrafish, opercular muscles function during respiration and act to open the mouth by moving the opercular bone (Lauder, 1982). One consequence of having the development of functionally interacting muscles regulated by one signalling pathway is that all muscles will be affected, simply by modulating this pathway. Such a mechanism might allow for coordinated changes to muscle systems during evolution, thus ensuring that their function is maintained. Interestingly, African seed finches that have evolved to eat tougher seeds show an increase in the size of muscles needed for jaw closing but not for jaw opening (Clabaut et al., 2009), revealing that differential changes to functional muscle systems do occur during evolution. If the opercular muscles are developing as a module, it is intriguing to consider how they might have changed during evolution and whether Ret signalling plays a conserved role in their development. The do and lo opercular muscles are not found in basal ray-finned fish, indicating that some aspects of the zebrafish opercular are derived features. By contrast, the opercular bone and two of the muscles (ao, hh sup) were present in the last common ancestor of fish and amniotes (Diogo et al., 2008; Zhu et al., 2009). In the lineage leading to mammals and birds, the opercular bone and associated muscles were lost and it is not clear what the homologues of opercular muscles are in mammals. We have shown that in zebrafish both the ao and hh sup require Ret signalling for their development and these muscles contain ret+ cells. The ao and hh arise from mesoderm of the second pharyngeal arch and in mammals this mesoderm forms the muscles of facial expression and platysma (Edgeworth, 1935). If Ret signalling has a role in patterning mammalian head muscles, it is likely to be required for the development of these muscles. We note that in mouse, Ret expression has been described in cells of the second pharyngeal arch (Pachnis et al., 1993). It is not clear whether these cells are present in muscle, but if Ret signalling has a conserved role in opercular muscle development, we would predict that it is needed for facial muscle development in mammals. No muscle perturbations have been described in mouse Ret-null mutants but, as they die owing to kidney defects at birth, head muscle defects might not have been apparent (Schuchardt et al., 1994). Likewise, it would be intriguing to assess whether altered Ret signalling in the head is associated with muscle perturbations in human craniofacial syndromes.
Acknowledgements
We thank Elisabeth Busch-Nentwich and Derek Stemple (Sanger Centre) for helping to generate the rethu2846 mutant and members of the Tübingen 2000 screen for assisting in the generation of the stmhy024 mutant. The authors are grateful to Anthony Graham, Simon Hughes and Ivo Lieberam for comments and discussions on this work. R.D.K. is funded by a BBSRC David Phillips Fellowship (BB/D020433/1).
References
Competing interests statement
The authors declare no competing financial interests.